Clinical Trial Update: Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating dasatinib or placebo with radiation therapy and temozolomide in newly diagnosed glioblastoma multiforme has completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• DASATINIB (Dasatinib)
• Radiation therapy
• Temozolomide (Temozolomide)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Brain and Central Nervous System Tumors | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-05-08